FDA Drug Application (200063) for CONTRAVE by OREXIGEN

Back to FDA Applications sponsored by OREXIGEN

Application Number200063
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage90MG;8MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCONTRAVE
Active IngredientBUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE



Back to FDA Applications sponsored by OREXIGEN

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.